Walgreens Boots Alliance (NASDAQ:WBA) had its price target lifted by stock analysts at Citigroup from $69.00 to $76.00 in a research report issued to clients and investors on Friday, Stock Target Advisor reports. The brokerage currently has a “neutral” rating on the pharmacy operator’s stock. Citigroup’s price objective suggests a potential upside of 3.40% from the stock’s previous close.

Other analysts have also recently issued reports about the company. TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. BidaskClub upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Loop Capital boosted their price target on Walgreens Boots Alliance to $80.00 and gave the stock a “buy” rating in a research report on Friday, June 29th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a research report on Tuesday, June 19th. Finally, Jefferies Financial Group cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating and dropped their price target for the stock from $85.00 to $65.00 in a research report on Friday, June 29th. One analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $77.56.

Shares of WBA opened at $73.50 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. Walgreens Boots Alliance has a one year low of $59.07 and a one year high of $80.68. The company has a market cap of $72.35 billion, a P/E ratio of 14.41, a PEG ratio of 1.11 and a beta of 1.04.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The firm had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. As a group, equities analysts predict that Walgreens Boots Alliance will post 5.98 EPS for the current year.

In related news, insider Stefano Pessina bought 1,697,438 shares of the company’s stock in a transaction on Monday, July 16th. The stock was bought at an average cost of $63.92 per share, for a total transaction of $108,500,236.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Ornella Barra bought 1,700,000 shares of the company’s stock in a transaction on Monday, July 16th. The stock was bought at an average price of $65.15 per share, with a total value of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in WBA. Massachusetts Financial Services Co. MA acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $199,228,000. LSV Asset Management lifted its stake in shares of Walgreens Boots Alliance by 17.2% in the 2nd quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock valued at $522,384,000 after purchasing an additional 1,277,546 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Walgreens Boots Alliance by 11.5% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock valued at $666,804,000 after purchasing an additional 1,143,819 shares during the last quarter. Burgundy Asset Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 16.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 7,161,408 shares of the pharmacy operator’s stock valued at $429,792,000 after purchasing an additional 986,275 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Walgreens Boots Alliance by 862.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,040,549 shares of the pharmacy operator’s stock valued at $62,449,000 after purchasing an additional 932,386 shares during the last quarter. 61.92% of the stock is currently owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Article: What are earnings reports?

Stock Target Advisor

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.